About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. Joaquim Vives Armengol, Senior Researcher Group Leader. Cell Therapy Service. Blood and Tissue Bank
Abstract: CA24114: A COST Action to create a pan-European network of SoHO establishments and collaborating partners for rapid and sustainable access to ATMPs Cell and Tissue processing institutions play a central role in managing Substances of Human Origin (SoHOs) and are increasingly engaged in the development of Advanced Therapy Medicinal Products (ATMPs) through strong links with healthcare systems, RDI labs, industry and regulators. To maximize impact and ensure equitable patient access, our COST Action project proposes an international network that fosters collaboration of all stakeholders involved across Europe and beyond while upholding ethical values, voluntary donation of SoHO, and professional and public education.
